豆国产96在线 | 亚洲-色一乱一伦一图一区二区精品-亚洲毛片无码专区亚洲乱-亚洲欧美日韩久久精品第一区

Technoderma Medicines, Inc.is a clinical stage biopharmaceutical company.

The company's current core research and development programs include innovative drugs for the treatment of androgenic alopecia, eczema/atopic dermatitis, psoriasis and lupus. TDM-105795, the world's leading small-molecule drug candidate for the treatment of androgenic alopecia, has now completed 2a clinical trials. TDM-180935, a novel JAK1/TYK2 inhibitor for eczema/atopic dermatitis, also completed a Phase 1 clinical trial in December 2023 with favorable safety results.